ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee

Anti-CD62L Antibody [B-S13] (A341880)

Mouse monoclonal [B-S13] IVD antibody to CD62L for Flow Cytometry.

Shipping Information

$40
Dispatched from St. Louis, MO.
Lead Time: 10-14 business days.
Name
Anti-CD62L Antibody [B-S13]
Description
Mouse monoclonal [B-S13] IVD antibody to CD62L.
Specificity
This product recognizesthe Leucocyte Endothelial Cell Adhesion Molecule-1 (LECAM-1), L-selectin, a 74-95 kDa protein; Cross reacts with mouse CD62L protein in cytometry.
Applications
Flow Cytometry
Reactivity
Human
Immunogen
CD62L transfected CHO cell line.
Host
Mouse
Clonality
Monoclonal
Clone ID
B-S13
Myeloma
Source: Myeloma X63/AG.8653 x Balb/c spleen cells
Isotype
Mouse IgG1 Kappa light chain
Conjugate

Unconjugated

Product Form
Liquid
Formulation
Phosphate-buffered saline with 1% BSA and 0.09% sodium azide.
Storage
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze/thaw cycles.
Intended Use
Use 10 µl to label 106 cells or 100 µl of whole blood.
General Notes
For bulk or custom IVD raw material requests, contact us directly.

IVD reagents are supplied in accordance with standard industry lead times of 4-6 weeks. Where products are in stock, dispatch typically occurs within 7-10 business days.
Synonyms
CD62 antigen-like family member L, L-selectin, LAM-1, LECAM1, Leukocyte adhesion molecule 1, Leukocyte surface antigen Leu-8, Leukocyte-endothelial cell adhesion molecule 1, LNHR, LYAM1, Lymph node homing receptor, SELL
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Publishing research using Anti-CD62L Antibody [B-S13] (A341880)? Please let us know so that we can list the citation on this page.

Alternative products to Anti-CD62L Antibody [B-S13] (A341880)

Proteins predicted to interact with CD62L

Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
99.9% Relevancy Score
99.9% Relevancy Score
99.8% Relevancy Score
99.8% Relevancy Score
99.5% Relevancy Score
98.8% Relevancy Score
98.6% Relevancy Score
97.6% Relevancy Score
97% Relevancy Score